Bill > SB00435

This bill aims to modify existing state statutes to allow the state government to import the active pharmaceutical ingredients for specific drugs, particularly focusing on levonorgestrel, mifepristone, and misoprostol. These drugs are commonly associated with reproductive health treatments, with levonorgestrel used in emergency contraception, and mifepristone and misoprostol typically used in medication abortion procedures. The primary purpose of the bill is to ensure broader access to these medications by enabling the state to directly import their active ingredients. By authorizing this importation, the state seeks to potentially reduce drug costs, mitigate supply chain disruptions, or address potential restrictions on these medications in other jurisdictions. The bill provides flexibility in the importation process by using language like "including, but not limited to," which suggests the state could potentially import active ingredients for other drugs beyond those specifically mentioned.

Justice

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00435&which_year=2025